KNUTSFORD, United Kingdom –
Mario Muredda join Fishawack Health (FH) as its new President of Marketing. He will join FH’s global and North American teams in a new period of growth designed to further enhance the data-driven marketing and omni-channel commercialization partner offering for its biopharma, medical technology clients and well-being.
“I am thrilled to be joining FH at such an important time for the organization,” says Muredda. “The company has put together a truly special and unique offering – a group of connected professionals who can drive end-to-end commercialization success for our healthcare partners. Everyone I’ve met has been so warm, welcoming and inspiring. The team’s energy is contagious. I’m excited to be part of a company whose core belief is ‘better health happens when we connect.’ Our teams are helping customers make meaningful connections every day – with professionals healthcare, patients, caregivers and advocacy groups.”
A veteran in pharmaceutical marketing and a people-first leader, Muredda joins the company after most recently serving as CEO at Harrison and Star. He brings extensive experience to leading healthcare marketing agencies with a focus on combining data, creativity, science and strategy to deliver solutions that improve health outcomes.
In his new role at FH, Muredda will lead the company’s marketing strategies and solutions to meet and exceed customer needs and the needs of their stakeholders, orchestrating connected and personalized experiences that combine scientific knowledge and strategic creativity.
Muredda will report to Gail Flockhart, Chief Commercial Officer (CCO). Jas Hummel will continue as Head of Global Marketing and Head of Sales and Marketing. Together, Muredda and Hummel are leading a team of more than 600 healthcare professionals in creative, strategic, scientific, technology, data, manufacturing, project management and customer management, bringing these teams together to ensure that FH to benefit from healthcare marketing around the globe. expertise.
Further expanding its UK marketing leadership, FH also welcomed Elly Price as Managing Director of Global Marketing. Price will report to Hummel, strengthening FH’s strong client relationships to ensure brands create greater connections with their stakeholders through exceptional marketing. Building on her operating philosophy, which equates collaboration with success, she will empower FH’s Global Marketing team to generate new ideas, leveraging their skills in strategy and creativity to deliver results for clients their own and the wider business. Having previously worked in senior leadership roles at Gray Healthcare Group, Price brings more than 25 years of experience in pharmaceutical marketing and deep expertise in a multitude of therapeutic areas.
The Marketing discipline is an integral part of the FH’s interdisciplinary offering in which the organization’s Medicine; Marketing; Politics; Value, Evidence and Access; and Consulting disciplines collaborate in designated teams. This approach empowers teams to bring a variety of lenses to meet each customer’s commercialization needs, breaking down silos and accelerating the development of new solutions.
“Mario and Elly join us at an exciting time in the evolution of our marketing offering at FH as we bring together our core expertise in science, analytics, creativity and digital technology to create brands that are dynamically intelligent, stay relevant and deliver growth by improving people’s health,” says Flockhart. “Over the past year, FH has continued to attract impressive healthcare marketing talent and received outstanding feedback from our clients, which is a testament to the exceptional expertise of our team members. By further uniting our global and North American offerings, we can more efficiently and effectively deliver as an analytics-driven brand agency of record to our clients and a growing and interconnected network of stakeholders that includes audience of healthcare professionals, patients, carers and consumers.
Muredda’s passion for making a difference is demonstrated through his position on the board of the Dream Foundation, the only national dream-granting organization serving terminally ill adults and their families by helping them fulfill their end-of-life dreams . This work complements FH’s philanthropic initiatives, in which its teams around the globe are encouraged and supported by the organization to give back to local communities.
Muredda is based in New York and Price is based in London, but both will work with teams in FH’s 20 locations spanning North America, Europe and Asia.
Founded in 2001, Fishawack Health (FH) is a purpose-built commercialization partner for the biopharmaceutical, medical technology and wellness industries. Over 1,500 of our experts combine their knowledge and expertise across our core disciplines – Medicine; Marketing; Politics; Value, Evidence and Access; and Consultation—to create the connections that make for better health.
We partner with our customers to navigate the complex and rapidly changing healthcare ecosystem. Together, we understand the potential of strategies and solutions to bring innovation into the hands of those who can benefit from it.
Visit us atFishawack.comand follow usI tweet ANDLinkedIn.
Leave a Reply